Evidence map›Paper›PMID 40615914›Full record

ArticleAlzheimer's research & therapy2025

Rescue of protein dyshomeostasis in hippocampal astrocytes from an Alzheimer's disease mouse model by stabilizing ER-mitochondrial interactions at a 20 nm distance.

Giulia Dematteis, Chunmei Gong, Justyna Malecka, Elisa Tonelli, Armando Genazzani, Laura Tapella, Anna Maria Eleuteri, Dmitry Lim, Laura Bonfili

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Glial Cells in Behavioral and Psychological Symptoms of Alzheimer's Disease.International journal of molecular sciences · 2026
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giulia Dematteis *Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Via Bovio 6, Novara, 28100, Italy.
Chunmei Gong *School of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, Camerino, MC, 62032, Italy.
Justyna MaleckaDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale, Via Bovio 6, Novara, 28100, Italy.
Elisa TonelliDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale, Via Bovio 6, Novara, 28100, Italy.
Armando GenazzaniDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Laura TapellaDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale, Via Bovio 6, Novara, 28100, Italy.
Anna Maria Eleuteri *School of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, Camerino, MC, 62032, Italy. annamaria.eleuteri@unicam.it.
Dmitry Lim *Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Via Bovio 6, Novara, 28100, Italy. dmitry.lim@uniupo.it.
Laura Bonfili *School of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, Camerino, MC, 62032, Italy. laura.bonfili@unicam.it.

Funding

European Molecular Biology Organization ASTF9854Fondazione CRT 1393-2017Jilin Agricultural University GrantNextGenerationEU PE00000006
6 · The paper itself

Abstract

backgroundAlzheimer's disease (AD) is the major age-related form of dementia in which dysfunctional ubiquitin-proteasome system (UPS) and autophagy represent primary mechanisms leading to accumulation of misfolded proteins, dysfunction of astroglial cells, neuroinflammation and neurodegeneration. Alterations of the endoplasmic reticulum (ER)-mitochondria contact sites (MERCS), specifically the shortening of the distance between the organelles, was proposed as a key mechanism of cell dysfunction in AD. However, its link to the impairment of the proteolytic system in AD remains unexplored.

methodsWe used, as a model, hippocampal astrocytes from 3xTg-AD mice expressing either control plasmid or synthetic linkers stabilizing ER-mitochondrial interaction at 10 nm (10 nm-EML) or at 20 nm (20 nm-EML). Alternatively, astrocytes were treated with mitochondrial Ca

resultsStabilization of MERCS at 20 nm (20 nm-MERCS), which promotes mitochondrial Ca

conclusionsOur results suggest that disruption of ER-mitochondrial interaction is a key factor for AD-related dysregulation of protein degradation and provide a proof that stabilization of MERCS at a defined distance and/or pharmacological rescue of mitochondrial Ca

Indexed as

Alzheimer DiseaseAstrocytesEndoplasmic ReticulumHippocampusMitochondriaProteostasisAnimalsAutophagyCalciumDisease Models, AnimalMiceMice, TransgenicCalciumAlzheimer’s diseaseAmorolfineAstrocytesAutophagyER-mitochondrial contact sitesER-mitochondrial distanceImmunoproteasomeLysosomal degradationMitochondrial calcium uptakeProteasome

Identifiers

PMID40615914
PMCPMC12228274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.